Peginterferon and Lovenox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Peginterferon (peginterferon alfa-2a; ribavirin) and Lovenox (enoxaparin sodium). Common drug interactions include anaemia among females and chronic obstructive pulmonary disease among males.

The phase IV clinical study analyzes what interactions people have when they take Peginterferon and Lovenox. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Peginterferon?

Peginterferon has active ingredients of peginterferon alfa-2a; ribavirin. It is often used in hepatitis c. eHealthMe is studying from 13,778 Peginterferon users. Check the latest studies of Peginterferon.

What is Lovenox?

Lovenox has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 48,149 Lovenox users. Check the latest studies of Lovenox.

On Jul, 07, 2026

11 people who take Peginterferon and Lovenox together, and have interactions are studied.

Peginterferon and Lovenox drug interactions.

What are the common drug interactions of Peginterferon and Lovenox, by gender? *:

female:

Anaemia (lack of blood)
Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
Anxiety
Death
Drug ineffective
Emotional distress
Eye haemorrhage (bleeding in the eye)
Fear
Injury
International normalised ratio increased

male:

Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Hypoxia (low oxygen in tissues)
Pneumonia
Pneumonia staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus)
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
Pneumothorax traumatic
Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
Pulmonary oedema (fluid accumulation in the lungs)
Respiratory distress (difficulty in breathing)
Respiratory failure (inadequate gas exchange by the respiratory system)

What are the common drug interactions of Peginterferon and Lovenox, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anaemia (lack of blood)
Hepatic neoplasm malignant (liver cancer)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Chronic respiratory failure
Drug abuse
International normalised ratio increased
Lung infection
Overdose
Self-injurious ideation
Suicide attempt

50-59:

Hypoxia (low oxygen in tissues)
Interstitial lung disease
Anaemia (lack of blood)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Haematocrit decreased
Haemoglobin decreased
Heart rate increased
Loss of consciousness
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
Pneumonia

60+:

Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
Anxiety
Irritability
Multi-organ failure (multisystem organ failure)
Pain
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Renal injury (kidney injury)
Retinal exudates (discharge from retina)

What are the existing conditions these people have? *

Portal Hypertension (increase in the blood pressure within a system of veins called the portal venous system): 2 people, 18.18%
Pain: 2 people, 18.18%
Oesophageal Disorder (disease of oesophagus): 2 people, 18.18%
Oedema (fluid collection in tissue): 2 people, 18.18%
Magnesium Deficiency (lack of magnesium): 2 people, 18.18%
Infection: 2 people, 18.18%
Encephalopathy (functioning of the brain is affected by some agent or condition): 2 people, 18.18%
Stress And Anxiety: 1 person, 9.09%
Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 9.09%
Immunodeficiency Disorders: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Peginterferon and Lovenox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously